NICE rec­om­mends Pfiz­er's mi­graine drug for use in the UK, with some re­stric­tions

The UK’s Na­tion­al In­sti­tute for Health and Care Ex­cel­lence (NICE) is rec­om­mend­ing Pfiz­er’s oral mi­graine drug rimegepant, known com­mer­cial­ly in the US as Nurtec and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.